116 related articles for article (PubMed ID: 35707936)
1. Improved survival of viral hepatocellular carcinoma but not non-viral hepatocellular carcinoma from 2000 to 2020: A multi-centre cohort study of 6007 patients from high-volume academic centres in Japan.
Toyoda H; Kariyama K; Hiraoka A; Tsuji K; Ishikawa T; Hatanaka T; Naganuma A; Yasuda S; Nouso K; Kakizaki S; Kumada T; Innes H; Johnson PJ
Aliment Pharmacol Ther; 2022 Aug; 56(4):694-701. PubMed ID: 35707936
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and prognosis of patients with hepatocellular carcinoma after the year 2000 in Japan.
Toyoda H; Kumada T; Tada T; Sone Y; Kaneoka Y; Maeda A
J Gastroenterol Hepatol; 2011 Dec; 26(12):1765-71. PubMed ID: 21615793
[TBL] [Abstract][Full Text] [Related]
3. Impact of hepatocellular carcinoma aetiology and liver function on the benefit of surveillance: A novel approach for the adjustment of lead-time bias.
Toyoda H; Kumada T; Tada T; Mizuno K; Hiraoka A; Tsuji K; Ishikawa T; Akita T; Tanaka J
Liver Int; 2018 Dec; 38(12):2260-2268. PubMed ID: 29981527
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
J Gastroenterol Hepatol; 2008 Mar; 23(3):459-66. PubMed ID: 17854425
[TBL] [Abstract][Full Text] [Related]
5. Effects of Positive Hepatitis B Core Antibody and Metabolic Disorders in Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus.
Lee HL; Bae SH; Lee J; Sung PS; Lee SW; Jang JW; Lee J; Choi JY; Han NI; Yoon SK
Cancer Control; 2021; 28():10732748211039758. PubMed ID: 34569320
[TBL] [Abstract][Full Text] [Related]
6. Impact of surveillance on survival of patients with initial hepatocellular carcinoma: a study from Japan.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1170-6. PubMed ID: 16890027
[TBL] [Abstract][Full Text] [Related]
7. Surveillance Rate and its Impact on Survival of Hepatocellular Carcinoma Patients in South Korea: A Cohort Study.
Im S; Jang ES; Lee JH; Lee CS; Kim BH; Chung JW; Kim JW; Jeong SH
Cancer Res Treat; 2019 Oct; 51(4):1357-1369. PubMed ID: 30744319
[TBL] [Abstract][Full Text] [Related]
8. Improvement of clinical management and outcome in hepatocellular carcinoma nowadays compared with historical cohorts.
Schellhaas B; Strobel D; Stumpf M; Ganslmayer M; Pfeifer L; Goertz RS; Neurath MF; Zopf S
Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1422-1427. PubMed ID: 30052538
[TBL] [Abstract][Full Text] [Related]
9. Characteristic differences of hepatocellular carcinoma in Japan, with special reference to liver weight at autopsy.
Horie Y; Maeda N; Kawasaki H; Suyama A
Hepatogastroenterology; 1997; 44(17):1407-12. PubMed ID: 9356864
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and Prognosis of Hepatocellular Carcinoma in Japanese Patients Undergoing Dialysis.
Toyoda H; Hiraoka A; Tada T; Michitaka K; Takaguchi K; Tsuji K; Itobayashi E; Takizawa D; Hirooka M; Koizumi Y; Ochi H; Joko K; Kisaka Y; Shimizu Y; Tajiri K; Tani J; Taniguchi T; Toshimori A; Fujioka S; Kumada T
Ther Apher Dial; 2017 Oct; 21(5):465-472. PubMed ID: 28880488
[TBL] [Abstract][Full Text] [Related]
11. Changes in the characteristics and survival rate of hepatocellular carcinoma from 1976 to 2000: analysis of 1365 patients in a single institution in Japan.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Hayashi K; Honda T; Kitabatake S; Kuzuya T; Nonogaki K; Kasugai T; Shimizu J
Cancer; 2004 Jun; 100(11):2415-21. PubMed ID: 15160346
[TBL] [Abstract][Full Text] [Related]
12. Clinical features of hepatocellular carcinoma in patients with autoimmune hepatitis in Japan.
Ohira H; Abe K; Takahashi A; Zeniya M; Ichida T
J Gastroenterol; 2013 Jan; 48(1):109-14. PubMed ID: 22688407
[TBL] [Abstract][Full Text] [Related]
13. Regular hospital visits improve the prognosis of hepatocellular carcinoma after initial diagnosis: A single regional community hospital study.
Watanabe M; Yomokori H; Takahashi Y; Minamino T; Kubo H; Okada T; Yamazaki H; Shibuya A; Koizum W
Turk J Gastroenterol; 2017 Sep; 28(5):353-360. PubMed ID: 28776496
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.
Worland T; Harrison B; Delmenico L; Dowling D
J Gastrointest Cancer; 2018 Dec; 49(4):476-480. PubMed ID: 28920172
[TBL] [Abstract][Full Text] [Related]
15. A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011-2015 update.
Tateishi R; Uchino K; Fujiwara N; Takehara T; Okanoue T; Seike M; Yoshiji H; Yatsuhashi H; Shimizu M; Torimura T; Moriyama M; Sakaida I; Okada H; Chiba T; Chuma M; Nakao K; Isomoto H; Sasaki Y; Kaneko S; Masaki T; Chayama K; Koike K
J Gastroenterol; 2019 Apr; 54(4):367-376. PubMed ID: 30498904
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting prognosis of small hepatocellular carcinoma in Taiwanese patients following hepatic resection.
Ko CJ; Chien SY; Chou CT; Chen LS; Chen ML; Chen YL
Can J Gastroenterol; 2011 Sep; 25(9):485-91. PubMed ID: 21912759
[TBL] [Abstract][Full Text] [Related]
17. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database.
Ding J; Wen Z
BMC Cancer; 2021 Oct; 21(1):1157. PubMed ID: 34715816
[TBL] [Abstract][Full Text] [Related]
18. Improved Survival in Patients with Viral Hepatitis-Induced Hepatocellular Carcinoma Undergoing Recommended Abdominal Ultrasound Surveillance in Ontario: A Population-Based Retrospective Cohort Study.
Thein HH; Campitelli MA; Yeung LT; Zaheen A; Yoshida EM; Earle CC
PLoS One; 2015; 10(9):e0138907. PubMed ID: 26398404
[TBL] [Abstract][Full Text] [Related]
19. The impact of newer treatment modalities on survival in patients with hepatocellular carcinoma.
Taura N; Hamasaki K; Nakao K; Ichikawa T; Nishimura D; Goto T; Fukuta M; Kawashimo H; Fujimoto M; Kusumoto K; Motoyoshi Y; Shibata H; Eguchi K
Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1177-83. PubMed ID: 16901768
[TBL] [Abstract][Full Text] [Related]
20. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
Mohamad B; Shah V; Onyshchenko M; Elshamy M; Aucejo F; Lopez R; Hanouneh IA; Alhaddad R; Alkhouri N
Hepatol Int; 2016 Jul; 10(4):632-9. PubMed ID: 26558795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
